Axona^® helps patients with Alzheimer's disease by addressing diminished cerebral glucose metabolism⁵

Extensive scientific evidence from more than three decades of research has established that diminished cerebral glucose metabolism (DCGM; also known as glucose hypometabolism) is a key underlying pathological change in the Alzheimer’s brain.¹  This leaves neurons less able to utilize glucose for fuel, leading to an energy shortage in the brain.¹  DCGM occurs early in the disease and may contribute to symptoms and disease progression.^1,6-8

Axona helps address this deficiency by providing ketones as an alternative fuel source for neurons.^4,5 Axona is the only available prescription medical food that addresses DCGM.^2,4  Adding Axona to traditional therapies addresses different aspects of Alzheimer’s disease at the same time and may help make the biggest impact in enhancing memory and cognition.^4,5

Add Axona. Add what's been missing from Alzheimer's therapy.

Axona is a prescription medical food intended for the clinical dietary management of the metabolic processes associated with mild to moderate Alzheimer's disease.